Pseudoprogression after treatment with the TGF-beta 2 inhibitor trabedersen in high-grade glioma patients von Bogdahn, U., Stockhammer, G., Mahapatra, A. K., Venkataramana, N. K., Oliushine, V. E., Parfenov, V. E., Poverennova, I. E., Jachimczak, P., Heinrichs, H., Schlingensiepen, K.

Volltext

Results of G004, a phase IIb study in recurrent glioblastoma patients with the TGF-b2 targeted compound AP 12009 von Bogdahn, U., Oliushine, V. E., Parfenov, V. E., Kunst, M., Mahapatra, A., Sastry, K. V., Venkataramana, K. N., Jachimczak, P., Hau, P., Schlingensiepen, K.

Volltext